Studies in mice revealed that IGF-1 treatment induced higher antibody levels [24], and in the absence of macrophage-derived IGF-1, the antibody titers elicited by subunit influenza vaccine were lower than in the wild-type condition [25]. The gene discussed is IGF1; the disease is influenza.